CD7-specific CAR-T Cell in the Treatment of CD7-positive Relapsed/Refractory Hematologic Tumors | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
CD7-specific CAR-T Cell in the Treatment of CD7-positive Relapsed/Refractory Hematologic Tumors	Hemic and Lymphatic Diseases, Neoplasms by Site, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm	Recruiting	Phase 1 / Phase 2	2024-12-06		NCT06720324

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Hebei Taihe Chunyu Biotechnology Co., Ltd	14
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	319

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Wuhan	China	77